which glp 1 drugs are approved for obesity The GLP-1 Agonists and Obesity: How Diabetes Drugs are Changing Non-Diabetic Lives — tl;dr pharmacy Patient education tips for GLP-1,

Semaglutide is a GLP-1 receptor agonist that helps reduce hunger and appetite, allowing you to eat fewer calories, lose weight, and manage your blood sugar levels

Emerging areas for more study include dietary modulation of endogenous GLP-1, strategies to improve compliance, nutritional priorities for weight maintenance post-cessation, combination or staged intensive lifestyle management, and diagnostic criteria for clinical obesity

The major limitation of this review is the limited availability of both animal and human studies

Jardiance (empagliflozin) is primarily approved for the treatment of type 2 diabetes

This suggests that the GLP-1 findings are unlikely to be an artifact of the studys design.

In patients with T2DM and NAFLD, dulaglutide has been shown to significantly reduce levels of liver injury biomarkers compared to placebo at 6 months of treatment [79]